Agilent Technologies (A) Stock Price, News & Analysis

Company Overview

Agilent Technologies, Inc. (NYSE:A) is a global leader in life sciences, diagnostics and applied chemical markets, providing laboratories worldwide with instruments, software, services and consumables. The company was established in 1999 as a spin-out from Hewlett-Packard and has since grown its portfolio to include analytical instruments such as liquid and gas chromatographs, mass spectrometers, atomic and molecular spectroscopy systems, and laboratory automation tools. Agilent’s solutions enable scientists and researchers to perform complex analyses with higher sensitivity, precision and throughput.

Agilent’s main business activities span drug discovery, biopharmaceutical development and manufacturing, food safety testing, environmental monitoring, chemical and energy research, as well as academic and government laboratories. Its offerings include bio-analytical reagents, diagnostic assays, DNA microarrays, clinical mass spectrometry solutions and digital pathogen detection technologies. In addition to instrumentation, Agilent provides software platforms for data management, workflow automation and compliance, as well as comprehensive service agreements and technical support to optimize lab productivity and uptime.

With a presence in over 100 countries, Agilent serves a diverse customer base across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. The company operates manufacturing facilities and regional centers of excellence on multiple continents, ensuring local support and rapid delivery of products and services. Agilent’s global outreach is reinforced by strategic partnerships with academic institutions, government agencies and industry consortia to advance scientific innovation and regulatory compliance.

Agilent is led by President and Chief Executive Officer Mike McMullen, with Mark Doak serving as Executive Vice President and Chief Financial Officer. The company’s executive leadership team brings extensive experience in scientific instrumentation and life sciences, guiding Agilent’s strategic initiatives in research and development, market expansion and digital transformation. Through continuous innovation and customer-centric solutions, Agilent aims to address emerging challenges in health, environment and energy, supporting the growth and success of laboratories around the world.

Key Stats

• Today's Range: $120.67 to $121.75
• 50-Day Range: $105.19 to $121.16
• 52-Week Range: $96.43 to $153.84
• Volume: 944,958 shs
• Average Volume: 1.85 million shs
• Market Capitalization: $34.42 billion
• P/E Ratio: 29.91
• Dividend Yield: 0.82%
• Price Target: $140.92
• Consensus Rating: Moderate Buy

Agilent Technologies Stock Analysis - MarketRank™

Agilent Technologies scored higher than 95% of companies evaluated by MarketBeat, and ranked 70th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Agilent Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.54, and is based on 7 buy ratings, 6 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Agilent Technologies has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 8.96%

Earnings Growth

Earnings for Agilent Technologies are expected to grow by 8.96% in the coming year, from $5.58 to $6.08 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Agilent Technologies is 29.91, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.66.

Price to Earnings Ratio vs. Sector

The P/E ratio of Agilent Technologies is 29.91, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.69.

Price to Earnings Growth Ratio

Agilent Technologies has a PEG Ratio of 3.68. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Agilent Technologies has a P/B Ratio of 5.61. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.45% of the float of Agilent Technologies has been sold short.

Short Interest Ratio / Days to Cover

Agilent Technologies has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Agilent Technologies has recently decreased by 0.72%, indicating that investor sentiment is improving.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Agilent Technologies has a dividend yield of 0.82%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Agilent Technologies has been increasing its dividend for 9 years.

Dividend Coverage

The dividend payout ratio of Agilent Technologies is 24.44%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Agilent Technologies will have a dividend payout ratio of 16.28% next year. This indicates that Agilent Technologies will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.6 / 5
• Environmental Score: -1.83

Percentage of Shares Shorted

1.45% of the float of Agilent Technologies has been sold short.

Short Interest Ratio / Days to Cover

Agilent Technologies has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Agilent Technologies has recently decreased by 0.72%, indicating that investor sentiment is improving.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 1.18

News Sentiment

Agilent Technologies has a news sentiment score of 1.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 21 news articles for Agilent Technologies this week, compared to 17 articles on an average week.

Search Interest

22 people have searched for A on MarketBeat in the last 30 days. This is an increase of 5% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Agilent Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Agilent Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $178,032.00 in company stock.

A Stock Analysis - Frequently Asked Questions

How have A shares performed this year?

Agilent Technologies' stock was trading at $134.34 at the beginning of 2025. Since then, A shares have decreased by 9.8% and is now trading at $121.1550.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) released its quarterly earnings results on Wednesday, May, 28th. The medical research company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.05. Agilent Technologies's revenue was up 6.0% compared to the same quarter last year.
Read the conference call transcript.

Does Agilent Technologies have any subsidiaries?

Agilent Technologies subsidiaries include Resolution Bioscience, BioTek Instruments, ACEA BIO, Young In Scientific Co. Ltd, ProZyme Inc, ULTRA Scientific, Genohm, and others.

Who are Agilent Technologies' major shareholders?

Top institutional shareholders of Agilent Technologies include Legacy Wealth Management LLC MS and Central Pacific Bank Trust Division. Insiders that own company stock include Michael R Mcmullen, Jacob Thaysen, Henrik Ancher-Jensen, Boon Hwee Koh, Heidi Fields, Michael Tang, Dominique Grau, Padraig Mcdonnell, Daniel K Podolsky, Rodney Gonsalves, Philip Binns and Judy L Brown.
View institutional ownership trends.

How do I buy shares of Agilent Technologies?

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Agilent Technologies investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), Voyager Therapeutics (VYGR) and iShares Micro-Cap ETF (IWC).

Company Calendar

• Record date for 4/23 Dividend: 4/01/2025
• Ex-Dividend for 4/23 Dividend: 4/01/2025
• Dividend Payable: 4/23/2025
• Last Earnings: 5/28/2025
• Record date for 7/23 Dividend: 7/01/2025
• Ex-Dividend for 7/23 Dividend: 7/01/2025
• Today: 7/06/2025
• Dividend Payable: 7/23/2025
• Next Earnings (Estimated): 8/20/2025
• Fiscal Year End: 10/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NYSE:A
• CIK: 1090872
• Web: www.agilent.com
• Phone: (800) 227-9770
• Fax: 408-345-8474
• Employees: 17,900
• Year Founded: 1999

Price Target and Rating

• Average Stock Price Target: $140.92
• High Stock Price Target: $165.00
• Low Stock Price Target: $116.00
• Potential Upside/Downside: +16.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.54
• Research Coverage: 13 Analysts

Profitability

• EPS (Trailing Twelve Months): $4.05
• Trailing P/E Ratio: 29.91
• Forward P/E Ratio: 21.71
• P/E Growth: 3.68
• Net Income: $1.29 billion
• Net Margins: 17.59%
• Pretax Margin: 20.68%
• Return on Equity: 25.92%
• Return on Assets: 13.24%

Debt

• Debt-to-Equity Ratio: 0.55
• Current Ratio: 2.09
• Quick Ratio: 1.60

Sales & Book Value

• Annual Sales: $6.51 billion
• Price / Sales: 5.29
• Cash Flow: $6.24 per share
• Price / Cash Flow: 19.42
• Book Value: $21.60 per share
• Price / Book: 5.61

Miscellaneous

• Outstanding Shares: 284,070,000
• Free Float: N/A
• Market Cap: $34.42 billion
• Optionable: Optionable
• Beta: 1.23